Cohort Studymoderate evidence
Real-world comparative effects of slow-release oral morphine vs. methadone on healthcare use for opioid use disorder: A population-based target trial emulation.
Addiction (Abingdon, England)·July 16, 2026·PMID 42464066
Why it mattersExpanding medication options for opioid use disorder is critical in the fentanyl era. These real-world findings suggest SROM is a viable alternative to methadone without increasing acute healthcare utilization, supporting its use in treatment programs.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled